Avience Biomedicals shares may make a strong debut as GMP signals 62% premium ahead of listing
Avience Biomedicals has launched an IPO worth Rs 30.24 crore, consisting of 14.54 lakh fresh shares. The IPO was met with exceptional investor interest, achieving a subscription rate of 385.32 times during the three-day…
Read full story